VEGFA and ischemia: Our regression analysis shows that each 10% increase in non-perfusion area decreased response likelihood by approximately 12%, suggesting that patients with more extensive ischemia might benefit from either more frequent anti-VEGF dosing or earlier supplemental panretinal photocoagulation targeting ischemic quadrants.